AbClon Inc.: South Korea’s Rising Biotech Star With Impressive Market Cap and Stock Surge
Explore AbClon Inc., a South Korean biotech leader with a $437B market cap, its stock’s 52‑week swings, and cutting‑edge R&D driving future growth.
2 minutes to read